
Zumutor Raises $7.3 Million to Advance Cancer Therapy Trials - Siliconindia
Zumutor is a biotechnology company focused on advancing cancer therapies. The company aims to enhance the effectiveness of cancer treatments through innovative trial methodologies. This funding round will support their ongoing clinical trials and development efforts.
Zumutor Raises $7.3 Million to Advance Cancer Therapy Trials Siliconindia
| Jun 17, 2026 | Telepatia | $33.0M | Series A | null |
| Jun 17, 2026 | Clair Health | $11.6M | Series A | United States |
| Jun 17, 2026 | Vali Health | $6.0M | — | United States |
| Jun 17, 2026 | Everlab | $65.0M | — | — |